Sign In
Buy DXCM
$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
Diabetes-related stocks take hit over weight loss drug craze
01:00pm, Saturday, 07'th Oct 2023
This segment originally aired on October 5, 2023 Weight loss drugs, like Novo Nordisk's (NVO) Ozempic, have become popular across healthcare providers in regard to diabetes treatment. Although use is
Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn
05:53am, Wednesday, 04'th Oct 2023
In recent months, diabetes stocks have retreated sharply, partly due to the increased popularity of the weight-loss drug Semaglutide. Some have contended that Semaglutide will greatly reduce the numbe
Weight-Loss-Drug Stock Sting May Be Easing for Device Makers
01:59pm, Monday, 02'nd Oct 2023
Wall Street says insulin pump maker Insulet and Tandem Diabetes, as well as glucose-monitor maker DexCom, look ready to rise after pressure from Novo Nordisk's Wegovy and Eli Lilly.
Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.
08:30am, Friday, 29'th Sep 2023
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2023 financial results after market close on Thursday, October 26, 2023. Management wi
Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks.
08:38am, Tuesday, 26'th Sep 2023
Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as ever.
3 Healthcare Stocks That Should Be on Every Investor's Radar This Fall
09:00am, Saturday, 23'rd Sep 2023
As of September 19, S&P 500 healthcare stocks were down 3.2% for the year. Of the 11 sectors, its year to date (YTD) performance is the second worst only behind utilities.
2 Healthcare Stocks That Could Make You Richer
10:07am, Friday, 22'nd Sep 2023
Vertex has almost no weak spots thanks to a solid core franchise and several promising programs. DexCom is helping improve the lives of diabetes patients, and the company still has lots of room to gro
3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought
02:37pm, Thursday, 21'st Sep 2023
A remarkable 30-year bull run for the Nasdaq 100 saw it gain nearly 4,000% by 2020. But, the party came to a screeching halt when the pandemic hit.
DexCom (DXCM) Launches Latest CGM Sensor ONE in France
09:02am, Monday, 18'th Sep 2023
DexCom's (DXCM) latest CGM sensor, DexCom ONE, secures reimbursement coverage in France, bringing the real-time CGM sensor to half a million diabetes patients in the country.
Will DexCom Stock Recover To Its Pre-Inflation Shock Highs Of $160?
09:00am, Monday, 18'th Sep 2023
The notable increase in DexCom's revenues over recent quarters has also contributed to the stock recovery.
Why DexCom Stock Dove by 5% Today
06:11pm, Friday, 15'th Sep 2023
A Raymond James analyst cut his price target on the specialty medical device maker. It was the second such price target cut so far this month.
Here's Why You Should Retain DexCom (DXCM) Stock for Now
09:01am, Thursday, 14'th Sep 2023
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
DexCom (DXCM) Rises 7% in One Week: What's Driving It?
09:50am, Tuesday, 12'th Sep 2023
DexCom's (DXCM) shares have rallied nearly 7% over the past week, presumably on positive outlook for its CGM devices amid rising competition.
With 2x Potential Returns Is DexCom A Better Pick Over Intuitive Surgical?
06:00am, Friday, 08'th Sep 2023
We believe DexCom stock (NASDAQ: DXCM) is a better healthcare pick than Intuitive Surgical stock (NASDAQ: ISRG).
Dexcom Denies Weight Loss Drug Threat To CGM Sales - I'd Be A Little Concerned
11:41am, Thursday, 07'th Sep 2023
DexCom is a major player in the continuous glucose monitoring space, with steadily growing revenues and a breakout year in 2020. DXCM's market cap valuation has reached $40 billion, leading to high ex
